Jornal Vascular Brasileiro
https://www.jvascbras.org/article/doi/10.1590/S1677-54492007000400004
Jornal Vascular Brasileiro
Original Article

Efeitos da prostaglandina E1 (PGE1) na gênese de capilares sanguíneos em músculo esquelético isquêmico de ratos: estudo histológico

Effects of prostaglandin E1 (PGE1) in the genesis of blood capillaries in rat ischemic skeletal muscle: histological study

Dorival Moreschi Jr.; Djalma José Fagundes; Luiz Eduardo Bersani Amado; Luzmarina Hernandes; Hugo Karling Moreschi

http://dx.doi.org/10.1590/S1677-54492007000400004 J Vasc Bras, vol.6, n4, p.316-324, 2007
PDF Português
PDF English
SciELO
Downloads: 0
Views: 1041

Resumo

CONTEXTO: A angiogênese terapêutica é uma modalidade de tratamento para pacientes com insuficiência arterial crônica que não têm indicação para revascularização direta ou angioplastia e que não tiveram uma resposta satisfatória ao tratamento clínico. Entre as drogas utilizadas para essa finalidade está a prostaglandina E1 (PGE1). OBJETIVO: Estudar os aspectos morfológicos na gênese de capilares sanguíneos em músculo esquelético do membro caudal de ratos submetidos à isquemia sob a ação da PGE1, administrada por via intramuscular (IM) ou endovenosa (EV). MÉTODOS: Foram utilizados 48 ratos, linhagem Wistar-UEM, distribuídos aleatoriamente em três grupos de 16, redistribuídos igualmente em dois subgrupos, observados no 7º e 14º dias, sendo um grupo controle onde apenas foi provocada a isquemia no membro, outro com a isquemia e a injeção da PGE1 via IM e outro com a isquemia e a injeção da PGE1 EV. Para análise dos resultados, foram realizadas a coloração com hematoxilina e eosina (HE) e coloração imuno-histoquímica. RESULTADOS: Constatou-se um aumento estatisticamente significativo no número de capilares nos subgrupos com o uso da PGE1 IM e EV, através da contagem nos cortes corados com HE. A imunomarcação não foi eficiente para a quantificação dos capilares. CONCLUSÕES: A PGE1, administrada por via IM ou EV, promoveu, após 14 dias de observação, um aumento no número de capilares no músculo esquelético de ratos submetido à isquemia, identificáveis histologicamente com a coloração em HE. A imunocoloração não permitiu estabelecer uma correlação com o aumento de vasos encontrados na coloração com HE.

Palavras-chave

Prostaglandina E1, angiogênese, isquemia

Abstract

BACKGROUND: Therapeutic angiogenesis is a treatment modality for patients with chronic arterial insufficiency who do not have indication for direct reconstruction or angioplasty and who were not successfully submitted to clinical treatment. Prostaglandin E1 (PGE1) is one of the drugs used for this purpose. OBJECTIVE: To study morphologic aspects in the genesis of blood capillaries in the lower limb skeletal muscle of rats submitted to ischemia under the action of intramuscular (IM) or endovenous (EV) PGE1. METHODS: Forty-eight Wistar-UEM rats were randomly distributed into three groups of 16, equally redistributed into two subgroups, observed at the 7th and 14th days as follows: one control group, which had only limb ischemia; one group with ischemia and IM injection of PGE1; and one group with ischemia and EV injection of PGE1. To analyze the results, hematoxylin-eosin (HE) and immunohistochemical staining were used. RESULTS: There was a statistically significant increase in the number of capillaries in the subgroups using IM or EV PGE1, through counting in the samples containing HE staining. Immunostaining was not efficient for the quantification of capillaries. CONCLUSIONS: IM or EV PGE1 resulted in an increase in number of capillaries in the skeletal muscle of rats submitted to ischemia after 14 days of observation, which was histologically identifiable through HE staining. Immunostaining was not successful in establishing a correlation with the increase in vessels found in HE staining.

Keywords

Prostaglandin E1, angiogenesis, ischemia

References

Becker C, Lacchini S, Muotri AR. Skeletal muscle cells expressing VEGF induce capillary formation and reduce cardiac injury in rats. Int J Cardiol. 2006;113:348-54.

Donnelly R, Yeung JM. Therapeutic angiogenesis: a step forward in intermittent claudication. Lancet. 2002;359:2048-50.

Gama AD. Etiopatogenia e evolução da doença aterosclerótica. Cirurgia vascular. 2001:129-38.

Hiatt WR. Drug therapy: medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344:1608-21.

Shyu KG, Chang H, Wang BW, Kuan P. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. Am J Med. 2003;114:85-92.

Couffinhal T, Dufourcq P, Daret D, Duplaà C. Les mécanismes de l'angiogenèse: Applications médicales et thérapeutiques. Rev Med Interne. 2001;22:1064-82.

Clover AJ, McCarthy MJ. Developing strategies for therapeutic angiogenesis: vascular endothelial growth factor alone may not be the answer. Br J Plast Surg. 2003;56:314.

Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest. 1999;103:1231-6.

Kenpinas WD. O desenvolvimento do sistema vascular. Doenças vasculares periféricas. 2002:3-17.

Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182-6.

Di Stefano R, Limbruno U, Barone D, Balbarini A. Angiogenesi terapeutica nell"ischemia critica degli arti inferiori: Revisione della litteratura e prospettive della ricerca sulle cellule staminali. Ital Heart J Suppl. 2004;5:1-13.

Speck NM, Focchi J, Alves AC, Osório CAB, Baracat EC. Relação entre angiogênese e estádio no carcinoma do endométrio. Rev Bras Ginecol Obstet. 2003;25:396-401.

Abo-Auda W, Benza RL. Therapeutic angiogenesis: review of current concepts and future directions. J Heart Lung Transplant. 2003;22:370-82.

Henry T. Therapeutic angiogenesis. BMJ. 1999;318:1536-9.

Emanueli C, Madeddu P. Angiogenesis gene therapy to rescue ischaemic tissues: achievements and future directions. Br J Pharmacol. 2001;133:951-8.

Darland DC, D"Amore PA. Blood vessel maturation: vascular development comes of age. J Clin Invest. 1999;103:157-8.

Chae JK, Kim I, Lim ST. Coadministration of Angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscl Thromb Vasc Biol. 2000;20:2573-8.

Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931-4.

Mehrabi MR, Ekmekcioglu C, Stanek B. Angiogenesis stimulation in explanted hearts from patients pré-treated with intravenous prostaglandin E (1). J Heart Lung Transplant. 2001;20:465-73.

Murohara T, Asahara T, Silver M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567-78.

Awas JA, Soteriou MC, Drougas JG, Stokes KA, Roberts LJ 2nd, Pinson CW. Plasma prostaglandin E1 concentrations and hemodynamics during intravenous infusions of prostaglandin E1 in humans and swine. Transplantation. 1996;61:1624-9.

Pacher R, Stanek B, Hülsmann M, Sinzinger H. Effect of prostaglandin E1 infusion in severe chronic heart failure. Prostaglandins. 1997;53:221-35.

Mehrabi MR, Serbecic N, Tamaddon F. Clinical benefit of prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium. Biomed Pharmacot. 2003;57:173-8.

Mehrabi MR, Serbecic N, Tamaddon F. Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease. Cardiovasc Res. 2002;56:214-24.

Hayashi S, Morishita R, Nakamura S. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral disease. Circulation. 1999;100(II):301-8.

Rakue H, Nakajima H, Katoh T. Low-dose basic fibroblast growth factor and vascular endothelial growth factor for angiogenesis in canine acute hindlimb insufficiency. Jpn Circ J. 1998;62:933-9.

Carmeliet P, Moons L, Collen D. Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis. Cardiovasc Res. 1998;39:8-33.

Suzuki M, Iso-o N, Takeshita S. Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. Biochem Biophys Res Commun. 2003;302:138-43.

Al-Khaldi A, Al-Sabti H, Galipeau J, Lachapelle K. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg. 2003;75:204-9.

Taniyama Y, Morishita R, Aoki M. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther. 2001;8:181-9.

Thompson WD, Li WW, Maragoudakis M. The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies. J Pathol. 2000;190:330-7.

Herzog S, Sager H, Khmelevski E, Deylig A, Ito WD. Collateral arteries grow from preexisting anastomoses in the rat hindlimb. Am J Physiol Heart Circ Physiol. 2002;283:H2012-20.

Namba T, Koike H, Murakami K. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation. 2003;108:2250-7.

Rosengart TK, Budenbender KT, Duenas M, Mack CA, Zhang QX, Isom OW. Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin. J Vasc Surg. 1977;26:302-12.

Ito WD, Arras M, Scholz D, Winkler B, Htun P, Schaper W. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol. 1997;273:H1255-65.

Williams RS, Annex BH. Plasticity of myocytes and capillaries. Circ Res. 2004;95:7-8.

Simons M. Angiogenesis: where do we stand now?. Circulation. 2005;111:1556-66.

Karetova D, Bultas J, Vondracek V, Aschermann M. Alprostadil: modes of action in peripheral arterial occlusive disease. Am J Ther. 1997;4:359-63.

Ziche M, Morbidelli L, Parenti A. Nitric oxide modulates angiogenesis elicited by prostaglandin E1 in rabbit cornea. Adv Prostaglandin Thromboxane Leukot Res. 1995;23:495-7.

Form DM, Auerbach R. PGE2 and angiogenesis. Proc Soc Exp Biol Med. 1983;172:214-8.

Barandon L, Leroux L, Dufourcq P. Gene therapy for chronic peripheral arterial disease: what role for the vascular surgeon ?. Ann Vasc Surg. 2004;18:758-65.

Ng YS, D"Amore PA. Therapeutic angiogenesis for cardiovascular disease. Curr Control Trials Cardiovasc Med. 2001;2:278-85.

Vale PR, Losordo DW, Symes JF, Isner JM. Factores de crecimiento para la angiogénesis terapéutica em las enfermedades cardiovasculares. Rev Esp Cardiol. 2001;54:1210-24.

Madrid JF, Diaz-Flores L, Gutiérrez R. Participation of angiogenesis from rat femoral veins in the neovascularization of adjacent occluded arteries. Histol Histopathol. 1998;13:1-11.

Díaz-Flores L, Madrid JF, Gutiérrez R. Arterial wall neovascularization induced by glycerol. Histol Histopathol. 2001;16:1175-81.

Scholz D, Ziegelhoeffer T, Helisch A. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol. 2002;34:775-87.

Diaz-Flores L, Gutierrez R, Valladares F, Varela H, Perez M. Intense vascular sprouting from rat femoral vein induced by Prostaglandins E1 and E2. Anat Rec. 1994;238:68-76.

Harada S, Nagy JA, Sullivan KA. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest. 1994;93:2490-6.

Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235:442-7.

Kofidis T, Nolte D, Simon AR. Restoration of blood flow and evaluation of corresponding angiogenic events by scanning electron microscopy after a single dose of VEGF in a model of peripheral vascular disease. Angiogenesis. 2002;5:87-92.

Downs KM. Florence Sabin and the mechanism of blood vesel lumenization during vasculogenesis. Microcirculation. 2003;10:5-25.

Egginton S, Gerritsen M. Lumen formation: in vivo versus in vitro observation. Microcirculation. 2003;10:45-61.

Zhou AL, Egginton S, Hudlická O. Capillary growth in overloaded hypertrophic adult rat skeletal muscle: An ultrastructural study. Anat Rec. 1998;252:49-63.

Baratella L, Arana-Chavez VE, Katchburian E. Macrophages and apoptosis in the stellate reticulum of the rat enamel organ. J Anat. 2000;197:303-6.

Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)"> Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)">
5ddeb8510e882508777279a1 jvb Articles
1677-7301 (Electronic)
J Vasc Bras ©2024 All rights reserved.

J Vasc Bras

Share this page
Page Sections